← Leaderboards
Joseph A. Baur
University Of Pennsylvania
$17,043,751
Attributed
$22,458,740
Total exposure
14
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,458,740 · 14
By mechanism
R01$15,176,269 · 6
U01$1,940,804 · 1
R56$1,401,883 · 1
P30$1,139,169 · 1
S10$750,000 · 1
R00$732,456 · 1
Top collaborators
- Daniel James Rader5 shared
- Donna M Huryn3 shared
- Tejvir S Khurana3 shared
- Madesh Muniswamy3 shared
- A. Clementina Mesaros2 shared
- Nirinjini N Naidoo2 shared
- Ravinder Reddy2 shared
- Patrick Seale1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Mitchell A. Lazar$48,884,193
- Payman Zamani$8,078,139
- Trevor M. Penning$29,812,455
- Hugh Lee Sweeney$44,337,022
- Daniel James Rader$77,348,993
Others in their field
Top investigators on “Metabolic”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,260,706
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$124,168,384
- Carol Nesel · Westat$116,355,411
Research focus
MetabolicTissuesMetabolismIn VivoCellsLiverPhysiologyPhenotypeGlucoseAffectMediatingEnzymesKnockout MiceAge RelatedObesityAnimalsAgingSignal TransductionMolecularGenerationsExperimental StudyNovel Therapeutic InterventionMitochondriaDiabetes Mellitus
Grant awards (47)
Validation of NAD+ measurements for human clinical studies: multi-method inter-laboratory standardization$939,100
U01 · FY2025 · AG
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging$798,756
R01 · FY2025 · DK · contact PI
Role of Activin Type II Receptor Signaling in Muscle Hypertrophy, Obesity, and Weight Loss$752,121
R01 · FY2025 · DK · contact PI
Understanding the roles of cardiac NAD pools and therapeutic effects of precursor supplements in heart failure$634,840
R01 · FY2025 · HL · contact PI
Mechanisms and therapeutic potential of blocking the mitochondrial Mg2+ channel Mrs2 in obesity and NAFLD$472,438
R01 · FY2025 · DK
Validation of NAD+ measurements for human clinical studies: multi-method inter-laboratory standardization$1,001,704
U01 · FY2024 · AG
Understanding the roles of cardiac NAD pools and therapeutic effects of precursor supplements in heart failure$644,038
R01 · FY2024 · HL · contact PI
Mechanisms and therapeutic potential of blocking the mitochondrial Mg2+ channel Mrs2 in obesity and NAFLD$503,933
R01 · FY2024 · DK
Understanding the roles of cardiac NAD pools and therapeutic effects of precursor supplements in heart failure$661,032
R01 · FY2023 · HL · contact PI
Mechanisms and therapeutic potential of blocking the mitochondrial Mg2+ channel Mrs2 in obesity and NAFLD$557,993
R01 · FY2023 · DK
HTS to identify compounds that increase NAD+ levels in neurons and muscle cells$373,195
R33 · FY2023 · NS
Understanding the roles of cardiac NAD pools and therapeutic effects of precursor supplements in heart failure$733,386
R01 · FY2022 · HL · contact PI
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging$560,737
R01 · FY2022 · DK · contact PI
HTS to identify compounds that increase NAD+ levels in neurons and muscle cells$279,416
R33 · FY2022 · NS
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging$560,737
R01 · FY2021 · DK · contact PI
Molecular mechanisms underlying the genetic association between PPP1R3B and hepatic steatosis$541,108
R01 · FY2021 · DK
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging$423,807
R01 · FY2021 · DK · contact PI
Mechanisms underlying the genetic association between PPP1R3B and Alzheimer's Disease$406,248
R01 · FY2021 · DK
Mouse Phenotyping, Physiology, and Metabolism Core$216,777
P30 · FY2021 · DK · contact PI
Molecular mechanisms underlying the genetic association between PPP1R3B and hepatic steatosis$691,510
R01 · FY2020 · DK
HTS to identify compounds that increase NAD+ levels in neurons and muscle cells$575,548
R61 · FY2020 · NS
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging$560,737
R01 · FY2020 · DK · contact PI
Mouse Phenotyping, Physiology, and Metabolism Core$216,777
P30 · FY2020 · DK · contact PI
Indirect calorimetry cages equipped for glucose and blood pressure telemetry$750,000
S10 · FY2019 · OD · contact PI
Pancreatic proteostasis connects sleep disruption to Alzheimers Disease$697,974
R56 · FY2019 · AG
Molecular mechanisms underlying the genetic association between PPP1R3B and hepatic steatosis$646,698
R01 · FY2019 · DK
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging$530,640
R01 · FY2019 · DK · contact PI
Mouse Phenotyping, Physiology, and Metabolism Core$216,777
P30 · FY2019 · DK · contact PI
Pancreatic proteostasis connects sleep disruption to Alzheimers Disease$703,909
R56 · FY2018 · AG
Molecular mechanisms underlying the genetic association between PPP1R3B and hepatic steatosis$630,762
R01 · FY2018 · DK
Mouse Phenotyping, Physiology, and Metabolism Core$216,777
P30 · FY2018 · DK · contact PI
Molecular Mechanisms of Rapamycin's effects on Health and longevity.$378,287
R01 · FY2017 · AG · contact PI
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging$361,508
R01 · FY2017 · DK · contact PI
Mouse Phenotyping, Physiology, and Metabolism Core$272,061
P30 · FY2017 · DK · contact PI
Molecular Mechanisms of Rapamycin's effects on Health and longevity.$377,843
R01 · FY2016 · AG · contact PI
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging$363,188
R01 · FY2016 · DK · contact PI
Molecular Mechanisms of Rapamycin's Effects on Health and Longevity$64,970
R01 · FY2016 · AG · contact PI
Molecular Mechanisms of Rapamycin's effects on Health and longevity.$405,691
R01 · FY2015 · AG · contact PI
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging$365,512
R01 · FY2015 · DK · contact PI
Molecular Mechanisms of Rapamycin's effects on Health and longevity.$410,967
R01 · FY2014 · AG · contact PI
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging$364,955
R01 · FY2014 · DK · contact PI
Targeting NAD Metabolism to Improve Glucose Homeostasis in Obesity and Aging$393,632
R01 · FY2013 · DK · contact PI
Molecular Mechanisms of Rapamycin's effects on Health and longevity.$378,195
R01 · FY2013 · AG · contact PI
Does SIRT1 regulate mammalian health and longevity?$236,946
R00 · FY2011 · AG · contact PI
Does SIRT1 regulate mammalian health and longevity?$246,510
R00 · FY2010 · AG · contact PI
Does SIRT1 regulate mammalian health and longevity?$249,000
R00 · FY2009 · AG · contact PI
Does SIRT1 regulate mammalian health and longevity?$90,000
K99 · FY2008 · AG · contact PI